MediPharm Labs Cautions Shareholders about Dissident Nominees' Governance Failures at Check-Cap Ltd.GlobeNewsWire • 05/23/25
Apollo Capital Comments on MediPharm Labs' Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual MeetingGlobeNewsWire • 05/23/25
MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in JuneGlobeNewsWire • 05/22/25
Apollo Capital Issues a With Prejudice Offer to MediPharm Labs and Its Board of Directors to Ensure Shareholder Rights Are Protected at the 2025 Annual MeetingGlobeNewsWire • 05/22/25
MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation FilingsGlobeNewsWire • 05/21/25
COMPLETE Board Change is Urgently Needed at MediPharm Labs! Apollo Technology Capital Corporation Files Amended and Restated Proxy Circular Detailing Prolonged Underperformance, Strategic Failures, Excessive Executive Compensation, and Troubling Lack of Transparency Under Current LeadershipPRNewsWire • 05/20/25
Apollo Capital Warns MediPharm Shareholders of Continued Value Destruction and Insolvency Risk Following Disastrous Q1 Financial ResultsPRNewsWire • 05/16/25
Apollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with ShareholdersPRNewsWire • 05/14/25
Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value DestructionPRNewsWire • 05/08/25
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial ResultsPRNewsWire • 03/26/25
MediPharm Labs Announces Termination of the Proposed Sale of Napanee Facility to Kensana HealthPRNewsWire • 02/10/25
MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana HealthPRNewsWire • 01/16/25
MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in BrazilPRNewsWire • 01/08/25